Aptinyx Inc. APTX
0.10 USD 0.00 (+0.00%)
Dec 29, 2023, 3:59 PM EST
0.09 Day range 0.096
0.009 52-week range 0.72
- EPS (ttm)
- -0.98
- P/E ratio
- -0.10
- Volume
- 231.13K
- Avg volume
- 132.92K
- Open
- 0.09155
- Previous close
- 0.096
- Day's range
- 0.09 – 0.096
- 52-week range
- 0.009 – 0.72
- Earnings date
- Jan 2, 2024
2Y -2.6240 (-96.47%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Jan 2, 2024
Expected Jan 2, 2024. Consensus EPS estimate 0.00.
Financials — quick view
APTX Revenue — quarterly 0
APTX Net income — quarterly -21.07M
APTX EPS — quarterly -0.31
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 2, 2024 | Sep 1, 2023 | -0.05 | — | — | — |
| Oct 5, 2023 | Jun 1, 2023 | -0.05 | — | — | — |
| May 18, 2023 | Mar 1, 2023 | -0.23 | — | — | — |
| Mar 30, 2023 | Dec 1, 2022 | -0.19 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.24 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | -0.29 | — | — | — |
News
Apotex Health Corp. (APTX) Opens the Market 
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO 
Stocks That Hit 52-Week Lows On Friday 
Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives 
Here's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Now 
COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar 
Stocks That Hit 52-Week Lows On Wednesday 
Stocks That Hit 52-Week Lows On Wednesday 
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 
Stocks That Hit 52-Week Lows On Wednesday
Your note
Sign in to keep a note on APTX — it syncs with the Stock Master app.